Picture of LumiraDx logo

LMDXF — LumiraDx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

LumiraDx Ltd expected to post a loss of 20 cents a share - Earnings Preview

* LumiraDx Ltd  LMDX.OQ   LMDX.O  is expected to show a fall
in
quarterly revenue when it reports  results on March 21. 
    * The George Town Cayman Islands-based   company is expected
to
report  a 64.7% decrease in revenue to $41.746 million from
$118.25 million a year ago, according to the mean estimate from
4 analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for LumiraDx Ltd is for
a
loss of 20 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for LumiraDx
Ltd is
$3​, above​ its last closing price of $0.87. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.26       -0.26      -0.47     Missed  -80.8
 Jun. 30 2022  -0.27       -0.26      -0.58     Missed  -120.3
 Mar. 31 2022  -0.07       -0.06      -0.22     Missed  -266.7
                                                        ​
 Dec. 31 2021  -0.08       -0.09      -0.15     Missed  -66.7
 ​​Sep.        -0.16       -0.24      -0.16     Beat    32.4
 30 2021                                                
                                                        ​
 This summary was machine generated March 17 at 12:40 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on LumiraDx

See all news